A Digital Health Innovator to
transform the patient’s journey
Servier Group at a glance (January 2019)
A total annual revenue of €4.2
billion
Servier brand medicines €2.9 billion
Servier generic medicines €1.3
billion
2nd French pharmaceutical company
33rd worldwide
3 Research centers, including 2 in France
16 Production sites, including 2 in France
15 International Centers of Therapeutic
Research (ICTRs)
25% of total revenue (from Servier
brand medicines) is invested in R&D,
excluding generic medicines
A workforce of 22 000
in 149 countries, 5000 in France
100 million patients treated daily
worldwide
Servier brand medicines and generic
medicines
A leader in cardiology
2nd in Europe, 5th worldwide
Entirely independent
Governed by a nonprofit foundation
26/09/2019 2
9/26/2019 3
With this heritage, Servier has created WeHealth Digital Medicine
Dedicated to healthcare digital
solutions
Dedicated to patients and healthcare providers
Dedicated to innovation and new technology
Supported by Corporate
Governance
Our history and heritage
to build an e-health portfolio that generates rapidly sustainable
revenue and profit
Caring for
each patient
WeHealth Digital Medicine at a glance: the vision
Designing new
practices through high-
quality digital solutions
Allowing the
convergence of
new knowledge in
healthcare
Innovating within
all ecosystems
26/09/2019 4
Upgrading
Using
Enabling
Building
Enabling each individual to generate
their own real-world data and be far
more engaged with their health
Upgrading the practice of medicine to
track our complex physiological
systems and understand the vast data
generated.
Using high-quality digital tools and
new technologies (sensors, software,
imaging, data/AI, genomics, …)
Building a new model of healthcare
integrating varied expertise (MD,
PHD, data scientists, researchers,
economists, engineers…)
What we want to do with digital health
26/09/2019 5
We want to improve the
daily lives of patients and
HCPs by using digital
technology.
We offer connected digital
solutions and services
based on medical data
value to better prevent
and predict disease
evolution.
We use an international
open innovative way to
identify the best solutions
and services.
We want to accelerate the
development, industrialization,
and distribution of these
innovations to provide
widespread access.
1
2
3
4
How WeHealth Digital Medicine
will fit the future
26/09/2019 6
26/09/2019 7
Startups Strategic Partners
Incubators Institutions
Identify startups
Innovate with end users
Accelerate development
Enhance network
Portfolio
From ideas to
commercialized products
Solutions, services, & data
Patient Societies
Foster early adoption
Work on data analytics
Learn by doing/feedback
Share best practices
We use an international open innovative way to identify the best
solutions and services
How WeHealth Digital Medicine will fit the future
26/09/2019 8
We want to accelerate the development, industrialization, and distribution of
these innovations to provide widespread access
How WeHealth Digital Medicine will fit the future
Strategic analysis Development Distribution &
deployment S
ou
rcin
g
Go
to
ma
rke
t
Early stage
Sc
ou
tin
g
Go
to
pa
rtn
ers
hip
Me
dic
al d
ata
va
lue
Medical data
value proposition
WeHealth Digital Medicine: 2015-2020 Milestones
26/09/2019 9
1st idea
Wearable ECG First 3
partnerships
& 1st CE Mark
4 solutions
commercialized
FR + US
20+ partnerships
2015 2017 2019
FDA 510k
2018
Go live
WeHealth
2016
2020
26/09/2019 10
WeHealth Digital Medicine: Targeted objectives
Global Picture Diseases
NEUROLOGY
ONCOLOGY
CARDIOVASCULAR
METABOLIC
IMMUNO-
INFLAMMATORY
Technologies/Digital
WIRELESS SENSORS
GENOMICS
IMAGING
INFORMATION SYSTEMS
DATA/AI
Sourcing
Clinical programs
Sales
Targeted Benefits
Diagnostic improvement
Lower hospitalizations
Better monitoring
Patient journey quality
Healthcare accessibility
Medical desert fight
Proximity for all
Data sharing
Time & cost savings
WeHealth Digital Medicine: the Value Chain A growing staff of 30 people connected with 500+ partners
Sourcing Development Sales
Identification Strategic
analysis Termsheet Contracts Commercialization
Communication
Congress
Events
Supply Chain Regulatory Affairs
Compliance
Cybersecurity
Data privacy
Innovate &
Valorize
Medical data value
proposal
Data Science
26/09/2019 11
WeHealth Digital Medicine: Unique Competitive Advantage
26/09/2019 12
• Synergistic and attractive
portfolio solutions at the point of
care
• Global patient journey coverage
solving patients’ and HCPs’ pain
points
• Portfolio versus stand alone
solutions to leverage sales force
optimization
• Multiple channels
• Step by step approach from 12 to
25 countries (EU, North America,
Asia, Australia…)
• No equity, milestone-driven
• Co-creation
• Co-development
• Exclusive license of distribution
• Communication support
• Secure IT and data privacy
• Market access expertise
• Right of first refusal option for any
new development
• Right of first negotiation for
geographic expansion
• Whole value chain
• Sales achievement
• New digital practices
• Lean startup (feedback), build & run
• Clinical/hospitals/users (patients or
HCPs) adoption programs
• Strategic partners network
Accelerate
Go to Market (Collaborative agreement )
Accelerate
Clinical Adoption (Operating model)
Accelerate Deployment
(Portfolio & geography) 1 2 3
26/09/2019 13
(e) (e) (e) (e) (e)
4
10
16
20
25
30
18-19 19-20 20-21 21-22 22-23 23-24
WeHealth Digital Medicine: Solutions’ launch plans (e)
26/09/2019 14
WeHealth Digital Medicine: medical data value proposition
Our platform will facilitate
the correlation of data to
better prevent and predict
after data anonymization
Our platform is HIPAA and
GDPR compliant as it is
has Microsoft Azure cloud
services.
Our digital solutions aim at
improving patients’
journeys
Both benefits for patients &
HCPs and participation in
lowering barriers to
healthcare
Our digital solutions respect
data privacy and
cybersecurity
Analysis of any medical
issues will serve
customers’ needs: • Patients
• Clinicians (hospitals, CROs,
pharmas…)
• Researchers
• Engineers
• Regulators
• Payers
SERVICES 2 1 PATIENTS/HCPs DATA PLATFORM 3